Hi all, I haven't held this stock for a few years, but always...

Hi all,

I haven't held this stock for a few years, but always keep an eye on it.

Yes, this seems at odds with the recent 4C. New (and old) investors would not have been expecting a CR based of the 4 C implying/stipulating they have enough cash to advance RAP through commercialisation.

With FDA Ann expected soon, clearly it seems management are not that confident. With FDA approval, they would likely raise cash at multiples of of the current SP, limiting dilution.

Seems like they are hedging their bets to me. If they have a suspicion that FDA will fail (or take many many more months) then raising cash at circa 24c is better than 15c (with FDA delay) or 10c (with FDA failure).

Just my thoughts.

Good luck all.